Locations:
Search
Reducing risk of recurrence 70%
Reduces muscle pain caused by cholesterol-lowering drugs
FDA makes MitraClip available to more patients with mitral regurgitation
Tafamidis is first FDA-approved drug to treat potentially fatal disease
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Oral immunotherapy drug is first of its kind
Cleveland Clinic takes an integrated approach to formulary management
Collaboration between Case Western Reserve University and Cleveland Clinic will use VR curriculum and team-based teaching to prepare students for health careers
Outgoing Chair of Cleveland Clinic's Board of Directors makes substantial gift in honor of Dr. Cosgrove
Intentionally designed to maximize interaction among students of all health disciplines
New Health Education Campus designed to encourage interaction and shared decision making
Advertisement
Advertisement